Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,099 | -7,678 | -12,440 | -832 | N/A |
| Other Working Capital | 44 | -261 | 380 | 20 | N/A |
| Other Operating Activity | 3,112 | 2,555 | 10,001 | 50 | 0 |
| Operating Cash Flow | $-8,943 | $-5,385 | $-2,059 | $-762 | $N/A |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | N/A | N/A | N/A | -100 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -100 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-100 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 24,907 | 12,209 | 900 | 2,056 | N/A |
| Common Stock Repurchased | -1,012 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $23,895 | $12,209 | $900 | $2,056 | $N/A |
| Exchange Rate Effect | 19 | -15 | -26 | 35 | N/A |
| Beginning Cash Position | 6,996 | 186 | 1,371 | 142 | N/A |
| End Cash Position | 21,967 | 6,996 | 186 | 1,371 | N/A |
| Net Cash Flow | $14,971 | $6,809 | $-1,185 | $1,229 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,943 | -5,385 | -2,059 | -762 | N/A |
| Free Cash Flow | -8,943 | -5,385 | -2,059 | -762 | 0 |